In Brief: Molecular Dynamics
This article was originally published in The Gray Sheet
Executive Summary
Molecular Dynamics: Andre Marion takes the helm of the bioanalytical systems company as interim president and CEO effective Oct. 13. Marion is former president and CEO of Perkin-Elmer's Applied Biosystems division and has served on the board of Molecular Dynamics. Outgoing company President and CEO James Iuliano announced his resignation Oct. 7 at the UBS Life Sciences conference in New York City. Iuliano, who joined Molecular Dynamics in 1990 and became president in 1993, cites family reasons in resigning from the post...